Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
30.05. | Astellas organizes action week to connect patients to advocacy groups | ||
30.05. | Akeso, Summit's ivonescimab delayed progression by 48% in certain lung cancers in first global phase 3 readout | ||
29.05. | 'Hanging on by our fingernails': Stealth CEO questions efficiency behind FDA rejection of rare disease drug | ||
29.05. | Sanofi spices up Type 1 diabetes awareness with sponsorship of new UK girl group | ||
29.05. | Alcon gains first FDA prescription drug nod since Novartis split, scoring with drops for dry eye disease | ||
29.05. | Drugmakers, trade groups and others voice concerns with pharma-specific tariffs | ||
29.05. | AACE Pharma slammed with FDA warning letter for contract manufacturer's shortfalls | ||
29.05. | Pfizer again found to have discredited pharma industry with COVID-19 vaccine tweets | ||
29.05. | Daiichi, Merck pull HER3-DXd filing at FDA after confirmatory trial misses survival endpoint | ||
29.05. | HHS axes Moderna's $590M pandemic bird flu vaccine contract, ending funding for late-phase trials | ||
28.05. | Alnylam choreographs new Givlaari promo in story of dancer's rare disease diagnosis | ||
28.05. | Scynexis says GSK on hook for $10M payment after phase 3 Brexafemme trial starts back up | ||
28.05. | Novartis emerged victorious in multi-month pursuit of Regulus and potential kidney blockbuster, filing shows | ||
28.05. | Big Pharma likely to endure Trump's tariff, pricing pressures, but threats to generics persist: S&P | ||
28.05. | InflaRx drops rare skin disease study for COVID med vilobelimab after futility signal | ||
27.05. | Sanofi eyes vaccine manufacturing in Vietnam amid tech transfer with local firm | ||
27.05. | CDC pulls COVID vaccine recommendation for pregnant women, healthy children: RFK Jr. | ||
27.05. | AbbVie's Allergan Aesthetics unit plots 202 layoffs after recent sales slide | ||
27.05. | Indivior nabs Sanofi, Endo alum as chief commercial officer | ||
27.05. | Olympic flame-out: Sanofi scorched for giving Paris 2024 tickets to UK patients | ||
27.05. | Seven top pharmas posted revenue declines in Q1. The common thread? All are US firms | ||
27.05. | FDA calls for additional manufacturing data in refusal letter for Savara's respiratory asset | ||
27.05. | Novartis expands strategic collaboration with Shanghai Pharma in China to cover eye drugs | ||
27.05. | Bio Usawa inks deal to deploy modular bio manufacturing units in Rwanda | ||
23.05. | AstraZeneca, Zero Prostate Cancer rev up early detection push at Memorial Day weekend NASCAR races |